"MEDCHEMEXPRESS"
GJA1 Protein, Human (His) -- 10µg 1 * 10 µG
Supplier: MEDCHEMEXPRESS
GJA1 Protein, Human (His) -- 10µg 1 * 10 µG
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
BAY 87-2243 IS A HIGHLY POTENT AND SELECTIVE INHIBITOR OF HYPOXIA- INDUCED HIF-1 ACTIVATION.IC50 VALUE: 2.0 NM(CA9 IN HCT116LUC CELLS) [1]TARGET: HIF-1IN VITRO: BAY 87-2243 INHIBITED L 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
BAY 87-2243 IS A HIGHLY POTENT AND SELECTIVE INHIBITOR OF HYPOXIA- INDUCED HIF-1 ACTIVATION.IC50 VALUE: 2.0 NM(CA9 IN HCT116LUC CELLS) [1]TARGET: HIF-1IN VITRO: BAY 87-2243 INHIBITED L 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ≥ 20 MG/ML, H2O: ＜ 1 MG/ML
PD0325901 (PD325901) IS SELECTIVE AND NON ATP-C OMPETITIVE MEK INHIBITOR WITH IC50 OF 0.33 NM.IC50 VALUE:TARGET: MEKPD0325901 IS A SELECTIVE MEK1 AND MEK2 INHIBITOR. 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ≥ 20 MG/ML, H2O: ＜ 1 MG/ML
PD0325901 (PD325901) IS SELECTIVE AND NON ATP-C OMPETITIVE MEK INHIBITOR WITH IC50 OF 0.33 NM.IC50 VALUE:TARGET: MEKPD0325901 IS A SELECTIVE MEK1 AND MEK2 INHIBITOR. 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ＞ 40 MG/ML
FIDAXOMICIN(OPT-80 PAR-101) IS A NEW CLASS OF NARROW SPECTRUM MACROCYCLIC ANTIBIOTIC DRUG SELECTIVE ERADICATION OF PATHOGENIC CLOSTRIDIUM DIFFICILE WITH MINIMAL DISRUPTION TO THE 1 * 5 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ＞ 40 MG/ML
FIDAXOMICIN(OPT-80 PAR-101) IS A NEW CLASS OF NARROW SPECTRUM MACROCYCLIC ANTIBIOTIC DRUG SELECTIVE ERADICATION OF PATHOGENIC CLOSTRIDIUM DIFFICILE WITH MINIMAL DISRUPTION TO THE 1 * 5 mg
Expand 1 Items
SOLUBILITY: DMSO: ≥ 36 MG/ML
RUXOLITINIB(INCB018424) IS THE FIRST POTENT, SELECTIVE, JAK1/2 INHIBITOR TO ENTER THE CLINIC WITH IC 50 OF 3.3 NM/2.8 NM, >130-FOLD SELECTIVITY FOR JAK1/2 VERSUS JAK3. IC50 VALUE: 3.3 NM/2.8 NM(JAK1/JAK2)TARGET: JAK1/2 1 * 5 mg
Supplier: MEDCHEMEXPRESS
SOLUBILITY: DMSO: ≥ 36 MG/ML
RUXOLITINIB(INCB018424) IS THE FIRST POTENT, SELECTIVE, JAK1/2 INHIBITOR TO ENTER THE CLINIC WITH IC 50 OF 3.3 NM/2.8 NM, >130-FOLD SELECTIVITY FOR JAK1/2 VERSUS JAK3. IC50 VALUE: 3.3 NM/2.8 NM(JAK1/JAK2)TARGET: JAK1/2 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
(+)-JQ1 CARBOXYLIC ACID IS THE CARBOXYLIC ACID FORM OF (+)-JQ1 FOR DERIVATIVE SYNTHESIS. 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
(+)-JQ1 CARBOXYLIC ACID IS THE CARBOXYLIC ACID FORM OF (+)-JQ1 FOR DERIVATIVE SYNTHESIS. 1 * 10 mg
Expand 1 Items
5-fluoro-N-{2-[(2S)-1-methyl-2-pyrrolidi 1 * 5 mg
Supplier: MEDCHEMEXPRESS
5-fluoro-N-{2-[(2S)-1-methyl-2-pyrrolidi 1 * 5 mg
Expand 1 Items
A-674563 (HYDROCHLORIDE) 1 * 10 mg
Supplier: MEDCHEMEXPRESS
A-674563 (HYDROCHLORIDE) 1 * 10 mg
Expand 1 Items
FORODESINE HYDROCHLORIDE 1 * 25 mg
Supplier: MEDCHEMEXPRESS
FORODESINE HYDROCHLORIDE 1 * 25 mg
Expand 1 Items
CM-4620/CALCIUM-RELEASE ACTIVATED CALCIUM-CHANNEL (CRAC CHANNEL) INHIBITOR, WITH IC50S OF 119 NM AND 895 NM FOR ORAI1/STIM1 AND ORAI 2/STIM1 CHANNELS 1 * 10 mg
Supplier: MEDCHEMEXPRESS
CM-4620/CALCIUM-RELEASE ACTIVATED CALCIUM-CHANNEL (CRAC CHANNEL) INHIBITOR, WITH IC50S OF 119 NM AND 895 NM FOR ORAI1/STIM1 AND ORAI 2/STIM1 CHANNELS 1 * 10 mg
Expand 1 Items
BRUSATOL - 10mg 1 * 10 mg
Supplier: MEDCHEMEXPRESS
BRUSATOL - 10mg 1 * 10 mg
Expand 1 Items
AZD-5991, 98.88% 1 * 10 mg
Supplier: MEDCHEMEXPRESS
AZD-5991, 98.88% 1 * 10 mg